Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indrani

Showing results (1531-1540 of 1,564) with videos related to

Pageof 157
Sort By:
Genes & Development|December 17, 2014
HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasiaTaranjit Singh Rai, John J Cole, David M Nelson, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancerStephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, et al.
Cancer Research|May 20, 2025
Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal CancerStephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, et al.
Human Genomics|July 12, 2005
Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variationMark D Shriver, Rui Mei, Esteban J Parra, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2021
Biosimilar strategic implementation at a large health systemIndrani Kar, Margaret Kronz, Evelina Kolychev, et al.
Plos One|June 26, 2025
Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented populationRavi Yadav, Saikat Dey, Ravichandiran Kumar, et al.
PLOS Global Public Health|July 2, 2024
A cluster-randomized trial of client and provider directed financial interventions to align incentives with appropriate case management in private medicine retailers: Results of the TESTsmART trial in Lagos, NigeriaTheodoor Visser, Jeremiah Laktabai, Emmah Kimachas, et al.
Lancet (London, England)|June 11, 2023
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trialCharlotte E Coles, Joanne S Haviland, Anna M Kirby, et al.
Physical Review Letters|July 31, 2025
Monolayer Control of Spin-Charge Conversion in van der Waals HeterostructuresKhasan Abdukayumov, Oliver Paull, Martin Mičica, et al.
Lancet (London, England)|August 7, 2017
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trialCharlotte E Coles, Clare L Griffin, Anna M Kirby, et al.
Pageof 157

Showing results (1531-1540 of 1,564) with videos related to

Sort By:
Pageof 157
Genes & Development|December 17, 2014
HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasiaTaranjit Singh Rai, John J Cole, David M Nelson, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancerStephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, et al.
Cancer Research|May 20, 2025
Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal CancerStephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, et al.
Human Genomics|July 12, 2005
Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variationMark D Shriver, Rui Mei, Esteban J Parra, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2021
Biosimilar strategic implementation at a large health systemIndrani Kar, Margaret Kronz, Evelina Kolychev, et al.
Plos One|June 26, 2025
Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented populationRavi Yadav, Saikat Dey, Ravichandiran Kumar, et al.
PLOS Global Public Health|July 2, 2024
A cluster-randomized trial of client and provider directed financial interventions to align incentives with appropriate case management in private medicine retailers: Results of the TESTsmART trial in Lagos, NigeriaTheodoor Visser, Jeremiah Laktabai, Emmah Kimachas, et al.
Lancet (London, England)|June 11, 2023
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trialCharlotte E Coles, Joanne S Haviland, Anna M Kirby, et al.
Physical Review Letters|July 31, 2025
Monolayer Control of Spin-Charge Conversion in van der Waals HeterostructuresKhasan Abdukayumov, Oliver Paull, Martin Mičica, et al.
Lancet (London, England)|August 7, 2017
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trialCharlotte E Coles, Clare L Griffin, Anna M Kirby, et al.
Pageof 157